Taking the measure of countermeasures: Leaders' views on the nation's capacity to develop biodefense countermeasures

被引：13

作者：

Gilfillan, L

Smith, BT ^{[1
]}

Inglesby, TV

Kodukula, K

Schuler, A

Lister, M

O'Toole, T

机构：

[1] Sarnoff Corp, Govt Operat, Princeton, NJ USA

[2] Univ Pittsburgh, Med Ctr, Ctr Biosecur, Baltimore, MD USA

来源：

BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE | 2004年 / 2卷 / 04期

关键词：

D O I：

10.1089/bsp.2004.2.320

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The purpose of this study was to gather and analyze the views of leaders from academia and government and industry regarding the capacity of the U.S. to develop biodefense countermeasures and to elicit their recommendations on steps that would improve the nation's capacities to succeed in these efforts.

引用

页码：320 / 327

页数：8

共 5 条

[1]

CONNOLLY C, 2003, WASHINGTON POST 0130

[2] The price of innovation: new estimates of drug development costs [J].